Hematopoiesis within the BM is ensured by hematopoietic stem cells (HSCs). This rare population is able to self-renew and to give rise to all mature blood cell types ([@bib51]). HSCs are tightly regulated to maintain these properties, and numerous factors have been shown to regulate quiescence, self-renewal, survival, and differentiation. The enormous functional demands and striking longevity of HSCs raise the question of whether they might be uniquely equipped to ensure their renewal. Recent studies have revealed that HSCs may indeed differ from their differentiated progenies at the level of constitutive cellular processes such as response to DNA damage or the regulation of energy metabolism. For example, mouse HSCs are less prone to DNA damage--induced apoptosis than committed progenitor populations ([@bib40]; [@bib26]). Control of reactive oxygen species levels is critical for BM homeostasis, and it is specifically regulated in HSCs by FoxO transcription factors ([@bib60]). Similarly, Lkb1, a master regulator of energy metabolism, is specifically required for HSC maintenance, regulating their function independently of TORC1 ([@bib15]; [@bib19]; [@bib43]).

Ribosome assembly in eukaryotic cells is a highly complex and coordinated process, requiring a large number of nonribosomal factors and snoRNAs ([@bib13]). Most of our knowledge of the ribosome biogenesis pathway comes from work performed in yeast, and much less is known about ribosome construction in metazoans. Over the past years, a growing body of evidence suggests that ribosome heterogeneity may participate in spatiotemporal regulation of gene expression ([@bib18]; [@bib66]). This raises the question of the mechanisms underlying the production of qualitatively different ribosomes and opens the possibility that ribosome assembly might follow different routes according to the cell type or environmental conditions. In human, defective ribosomal synthesis has been associated with BM failure syndromes and skeletal defects as well as predisposition to cancer ([@bib16]; [@bib45]). Why such a general cellular defect causes specific developmental and hematopoietic phenotypes in patients and the corresponding animal models is not fully understood. Differential sensitivity and cellular responses to ribosomal stress could explain some of these specificities ([@bib9]; [@bib11]).

*Notchless* (*Nle*) was originally identified in *Drosophila melanogaster* during a genetic screen for modifiers of Notch activity, although its mechanism of action has since remained elusive ([@bib57]). NLE protein is an evolutionary conserved member of the large WD-repeat protein family containing a predicted C-terminal β propeller consisting of eight WD domains and an N-terminal extension. The yeast NLE orthologue Rsa4 acts in ribosome large subunit biogenesis ([@bib10]; [@bib62]). The N-terminal domain of Rsa4 interacts with the metal ion--dependent adhesion site domain of the AAA-ATPase Rea1/Mdn1, and this interaction is essential for removal of pre-60S factors and progression of 60S biogenesis ([@bib62]). Indeed, yeast cells deficient for *RSA4* or expressing a mutated protein unable to interact with Rea1 displayed impaired rRNA processing, nuclear accumulation of pre-60S particles, and reduction of mature 60S subunits ([@bib10]; [@bib62]). Implication of *Nle* in ribosome biogenesis has not been directly addressed so far in other eukaryotes. Nonetheless, *Solanum chacoense* NLE and MDN1 were found to interact in yeast two-hybrid assay ([@bib5]), and similar phenotypes were obtained after knockdown of *Nle* and orthologues of yeast genes implicated in ribosome biogenesis in *Arabidopsis thaliana* and *Caenorhabditis elegans* ([@bib64]; [@bib6]). In the mouse, we previously reported that constitutive *Nle* loss of function results in early embryonic lethality and that *Nle* is mainly required in inner cell mass cells, being instrumental for their survival ([@bib8]).

Here, we uncover the critical role of *Nle* in mouse adult hematopoiesis using an inducible conditional mutagenesis strategy. Using noncompetitive and competitive transplantations, we show that *Nle* is cell-autonomously required for the maintenance of functional HSCs under both homeostasis and cytopenic conditions. Upon *Nle* deletion, HSCs entered the cell cycle, indicating that *Nle* is essential for maintaining HSC quiescence. In contrast, *Nle* is dispensable for cycling restricted progenitors and differentiated cells. We also demonstrate that the role of *Nle* in ribosome biogenesis is conserved in the mouse and show that *Nle* deficiency affects ribosome biogenesis in HSCs and multipotent progenitors (MPPs) but not in more restricted progenitors. Finally, we show that ribosome biogenesis defects are associated with p53 activation in *Nle*-deficient HSCs/MPPs, which in turn causes their elimination. Collectively, our findings establish an essential role for *Nle* in HSC/MPP function and uncover previously unsuspected differences in ribosome biogenesis between stem cells and restricted progenitor populations within the same lineage.

RESULTS
=======

Ubiquitous *Nle* inactivation induces BM failure
------------------------------------------------

To address *Nle* function in the adult, we generated a conditional allele of *Nle* ([Fig. S1, A--C](http://www.jem.org/cgi/content/full/jem.20122019/DC1){#supp1}) and performed acute conditional inactivation using the *Rosa26^CreERT2^* line ([@bib21]). Adult *Rosa26^CreERT2/+^*; *Nle^Flox/null^* mice (named Nle^cKO^ hereafter) were injected three or five consecutive days with tamoxifen. Because activation of the CreERT2 recombinase could potentially affect cell physiology ([@bib42]; [@bib22]), we used *Rosa26^CreERT2/+^*; *Nle^Flox/+^* (named control hereafter) littermates exposed to the same regimen as control. In both control and Nle^cKO^ mice, efficient conversion of *Nle^Flox^* into *Nle^Del^* allele was observed in all organs except the brain (not depicted). Noticeably, all Nle^cKO^ mice died within 10--13 d after the first injection ([Fig. 1 A](#fig1){ref-type="fig"}). Examination of Nle^cKO^ mice euthanized on days 7--9 revealed alterations of intestinal gut epithelium histology (not depicted) and major defects in BM and secondary lymphoid organs (see below). This led us to analyze in more detail the role of *Nle* in hematopoiesis.

![***Nle* inactivation induces rapid BM failure.** (A) Survival curve of control and Nle^cKO^ (cKO) mice after Cre induction (*n* ≥ 13 per genotype). (B) Western blot analysis of sorted Lin^−^ and Lin^+^ BM cells and splenic cells from control or Nle^cKO^ mouse before and 4 or 7 d after Cre induction. Data are from one representative of three independent experiments. (C) RT-QPCR analysis of *Nle* mRNA expression levels in various sorted BM populations from untreated control mice (*n* = 3). Bars are means (SD); this experiment was performed three times. (D and E) PCR analysis on BM cells from control and Nle^cKO^ mice before or 5 d after Cre induction (D) and on BM and PB cells from control mice 6 or 9 mo after Cre induction (E). Similar results were obtained from at least two independent experiments. DNA obtained from *Nle^Flox/Del^* mice was used as a control of allele amplification (lane F/Δ). (F) Spleen, thymus, and BM cellularity at different time points after Cre induction. Depicted are the means (SD) of *n* = 5--28 mice per genotype pooled from at least two independent experiments. (G) Representative pictures from one experiment (*n* = 3 per genotype) showing hematoxylin and eosin staining of transversal sections of the femur from control and Nle^cKO^ mice 9 d after Cre induction. Bars, 200 µm. (H) Count of various BM hematopoietic cell populations 7 d after Cre induction (*n* ≥ 4 per genotype, from one experiment). Bars are means (SD). \*, P \< 0.05; \*\*, P \< 0.005; \*\*\*, P \< 0.0005.](JEM_20122019_Fig1){#fig1}

First, we monitored *Nle* expression in hematopoietic cells by Western blot and real-time RT-QPCR. NLE protein was detected in BM and spleen in control mice ([Fig. 1 B](#fig1){ref-type="fig"}). In the BM, lineage-negative (Lin^−^) immature cells expressed higher levels of protein than lineage-positive (Lin^+^) cells ([Fig. 1 B](#fig1){ref-type="fig"}). Lin^−^ cells from noninjected control were sorted into HSCs (Lin^−^ Sca-1^+^ c-Kit^+^ CD34^−^ \[LSK CD34^−^\]), MPPs (Lin^−^ Sca-1^+^ c-Kit^+^ CD34^+^ \[LSK CD34^+^\]), common myeloid progenitors (CMPs; Lin^−^ Sca-1^−^ c-Kit^+^ CD34^+^), and common lymphoid progenitors (CLPs; Lin^−^ Sca-1^low^ c-Kit^low^ Il7rα^+^; see the gating strategy in [Fig. S2](http://www.jem.org/cgi/content/full/jem.20122019/DC1){#supp2}). Higher *Nle* mRNA levels were found in LSK CD34^−^, LSK CD34^+^, CMPs, and CLPs compared with CD19^+^ B cells or total BM containing a majority of Lin^+^ cells ([Fig. 1 C](#fig1){ref-type="fig"}). We then verified that in control and Nle^cKO^ mice, *Nle* deletion was effective in the hematopoietic tissue. Control and Nle^cKO^ mice were injected with tamoxifen, and PCR analysis was performed on BM and peripheral blood (PB) genomic DNA at various time points after Cre induction. Efficiency of recombination was estimated through comparison with samples of DNA from hematopoietic cells containing different ratios of *Nle^Flox^* and *Nle^Del^* alleles (Fig. S1, D and E). After Cre induction, high deletion efficiency was detected in BM, thymic, and splenic cells from control and Nle^cKO^ mice ([Fig. 1 D](#fig1){ref-type="fig"} and not depicted). This was further confirmed by the dramatic decrease in NLE protein levels in Nle^cKO^ BM and spleen ([Fig. 1 B](#fig1){ref-type="fig"}). At later time points (up to 9 mo), the vast majority of hematopoietic cells from control mice were carrying an *Nle^Del^* allele ([Fig. 1 E](#fig1){ref-type="fig"}), indicating that *Nle* deletion mediated by the *Rosa26^CreERT2^* allele was effective in HSCs.

During the autopsy, we noticed a marked reduction in the size of hematopoietic and lymphoid organs from Nle^cKO^ mice. At day 9, the numbers of cells in thymus, spleen, and BM were strongly reduced ([Fig. 1 F](#fig1){ref-type="fig"}). In addition, hematoxylin and eosin staining of bone sections revealed severe hypocellularity in Nle^cKO^ BM, showing capillaries saturated with erythrocytes ([Fig. 1 G](#fig1){ref-type="fig"}). Flow cytometry of Nle^cKO^ BM revealed that most hematopoietic lineages were severely affected ([Fig. 1 H](#fig1){ref-type="fig"}). Together, these results show that *Nle* is critically required for hematopoiesis.

HSCs and immature progenitors are rapidly compromised after *Nle* inactivation
------------------------------------------------------------------------------

We next monitored the consequences of *Nle* inactivation on the BM immature cell populations and observed a strong diminution in the number of CMPs and CLPs 1 wk after tamoxifen injection ([Fig. 2 A](#fig2){ref-type="fig"}). Flow cytometry analysis also showed a rapid and dramatic decrease in the number of immature Lin^−^ Sca-1^+^ c-Kit^+^ (LSK) cells after *Nle* inactivation. Both HSC-enriched LSK CD34^−^ and MPP LSK CD34^+^ cell populations were virtually undetectable as early as 5 d after the first tamoxifen treatment ([Fig. 2 B](#fig2){ref-type="fig"} and not depicted). We noticed on the Nle^cKO^ FACS profiles a transitory Lin^−^ Sca-1^+^ c-Kit^low^ cell population (see the cells within the black circle in [Fig. 2 D](#fig2){ref-type="fig"}), suggesting that in the absence of *Nle*, HSCs and MPPs down-regulate c-Kit expression at their surface. A similar situation was previously reported in 5-FU--treated mice, in which HSC activation after abrupt loss of hematopoietic mature cells and precursors is associated with low c-Kit expression at their membranes ([@bib55]). We therefore decided to reanalyze HSCs in Nle^cKO^ BM irrespectively of c-Kit expression, using the SLAM family receptors CD48 and CD150 ([@bib31]). Although less pronounced than for LSK CD34^−^ cells, we observed a rapid decrease in the number of HSC-enriched Lin^−^ Sca-1^+^ CD150^+^ CD48^−^ cells (SLAM) in Nle^cKO^ BM compared with control ([Fig. 2 C](#fig2){ref-type="fig"}). Strikingly, although a vast majority of control SLAM cells expressed high levels of c-Kit receptor at their surface, the proportion of c-Kit^high^ cells among SLAM cells was drastically reduced in Nle^cKO^ BM 5 and 7 d after Cre induction (17% and 2%, respectively). Down-regulation of c-Kit expression was probably effective on other populations, including CMPs (see for example [Fig. 2 D](#fig2){ref-type="fig"}). Nonetheless, by itself, it did not account for the reduction of phenotypic CMPs and CLPs in Nle^cKO^ mice as shown by the decreased number of Lin^−^ CD34^+^ and Lin^−^ Il7rα^+^ cell populations that include CMPs and CLPs, respectively ([Fig. 2 A](#fig2){ref-type="fig"}). We also monitored Nle^cKO^ mice 5 d after Cre induction for the presence of Lin^−^ PB cells and did not find any signs of increased HSC mobilization (not depicted). Altogether, these data show that phenotypic HSCs and immature progenitors are rapidly lost after *Nle* deficiency.

![***Nle* deletion provokes HSC and immature progenitor disappearance.** (A) Count of myeloid and lymphoid progenitors per hindlimb 7 d after Cre induction. Bars are means (SD) for *n* ≥ 3 mice per genotype. This experiment was performed twice. (B) Count of LSK CD34^−^ cells per hindlimb at different time points after Cre induction. Bars are means (SD) for *n* ≥ 13 mice per genotype pooled from at least three independent experiments. (C) Count of SLAM cells per hindlimb at different time points after Cre induction. Bars are means (SD) for *n* = 6--13 mice per genotype pooled from two or three independent experiments. (D) Representative FACS profiles of BM cells from control or Nle^cKO^ mice at day 5. Cells were labeled with LSK (left) or SLAM (middle) markers. Nle^cKO^ SLAM cells express lower levels of c-Kit (right). Similar results were obtained from two independent experiments. The black circle indicates a transitory Lin^−^ Sca-1^+^ c-Kit^low^ cell popluation in Nle^cKO^ BM. (E) Schematic representation of the transplantation strategy. Both control and Nle^cKO^ mice were injected five consecutive days before transplantation. (F) PCR analysis was performed on BM at the time of transplantation and after 9 mo and on PB cells at different time points after transplantation. Similar results were obtained from two independent experiments. \*, P \< 0.05; \*\*, P \< 0.005; \*\*\*, P \< 0.0005.](JEM_20122019R_Fig2){#fig2}

To address the possibility that functional HSCs with a modified phenotype may nevertheless persist in Nle^cKO^ BM, we performed total BM transplantation experiments. BM cells were recovered from control and Nle^cKO^ mice 5 d after Cre induction and transferred into sublethally irradiated mice ([Fig. 2 E](#fig2){ref-type="fig"}). By the time of transplantation, efficient deletion of the *Nle^Flox^* allele was observed in both control and Nle^cKO^ donor cells ([Fig. 2 F](#fig2){ref-type="fig"}, left). In contrast to control, the *Nle^Del^* allele could neither be detected in the blood of mice transplanted with Nle^cKO^ BM 3.5 and 7 wk or 9 mo after engraftment nor in the BM after 9 mo ([Fig. 2 F](#fig2){ref-type="fig"}). This indicates that the reconstituting activity of Nle^cKO^ BM was limited to *Nle*-proficient nonrecombined cells. These data show that *Nle* function is critically required for HSC and immature progenitor activity and function.

Reduced quiescence of *Nle*-deficient HSCs and MPPs
---------------------------------------------------

To determine the mechanisms by which *Nle* deletion induces stem and progenitor cell loss, we analyzed Nle^cKO^ BM cells shortly after Cre induction. Because *Nle* has previously been shown to play a role in cell survival ([@bib8]; [@bib51]), we first examined whether increased cell death could be responsible for the rapid exhaustion of HSCs and MPPs in Nle^cKO^ mice. Using Annexin V/7AAD labeling, we analyzed freshly isolated Nle^cKO^ BM cells at days 3 and 5, when no or moderate defects in BM homeostasis were observed ([Figs. 1 F](#fig1){ref-type="fig"} and [2, A--D](#fig2){ref-type="fig"}). At either time point, no increase in the frequency of Annexin V^+^7AAD^−^ (apoptotic) or Annexin V^+^7AAD^+^ (dead) cells among total BM cells, SLAM cells, and immature progenitors (LSK CD34^+^, CMPs, and CLPs at day 3 or Lin^−^ Sca-1^+^ CD150^+^ CD48^+^ at day 5) was detected ([Fig. 3, A and B](#fig3){ref-type="fig"}; and not depicted). At day 5, a significant decrease in the frequency of apoptosis among SLAM cells was observed in Nle^cKO^ mice ([Fig. 3 A](#fig3){ref-type="fig"}), although no HSC activity was found in the BM of such animals ([Fig. 2 F](#fig2){ref-type="fig"}). Similarly, a TUNEL assay performed on control and Nle^cKO^ mice at day 4 did not show an increased cell death of HSCs and immature progenitors after *Nle* inactivation (not depicted). We then examined the cell cycle status of control and Nle^cKO^ BM cells using Ki67 and Hoechst staining. Importantly, as early as 3 d after Cre induction, there was a significant decrease in the frequency of G~0~ cells between control and Nle^cKO^ SLAM or LSK CD34^−^ and MPPs ([Fig. 3](#fig3){ref-type="fig"}, C \[left\] and D; and not depicted). In all populations, Ki67^+^ cells were identically distributed among G1 and S-G2/M between control and Nle^cKO^ mice ([Fig. 3 C](#fig3){ref-type="fig"}, right; and not depicted), indicating that cycling *Nle*-deficient BM cells have cycling parameters similar to control cells. We next examined SLAM cells for various cell cycle regulators by RT-QPCR ([Fig. 3 E](#fig3){ref-type="fig"}). As expected, a massive reduction of *Nle* mRNA levels was observed in Nle^cKO^ SLAM cells. For most genes tested, no differences were observed between control and Nle^cKO^ SLAM cells. Consistent with the higher proportion of cycling cells, cyclin A2, cyclin B1, and cyclin D1 mRNA levels were slightly increased in *Nle*-deficient SLAM cells. Strikingly, a strong up-regulation of *Cdkn1a* (*p21*) mRNA level was observed in Nle^cKO^ SLAM cells, suggesting that depletion of NLE protein in HSCs causes the activation of p53 (see below). However, this up-regulation was not accompanied by a potent cell cycle arrest, as visualized by FACS analysis ([Fig. 3, C and D](#fig3){ref-type="fig"}). A similar situation has been previously reported during HSC mobilization ([@bib53]). Up-regulation of *Cdkn1a* (*p21*) together with increased cell cycle entry of HSCs has also been described after x-ray exposure ([@bib26]). Altogether, our data indicate that *Nle* is required for the maintenance of HSC quiescence.

![**Cell death and proliferation of *Nle*-deficient HSCs and progenitors.** (A and B) SLAM cells were stained with Annexin V/7AAD. (A) Quantitative results for dead and apoptotic cells and means (SD) are shown (*n* = 3 per genotype). (B) Representative FACS profiles are shown. This experiment was performed independently twice. (C and D) BM cells were stained for Ki67 and Hoechst 3 d after Cre induction. (C) The relative number of Ki67^−^ cells within the LSK CD34^−^ population is indicated (left; *n* ≥ 14 per genotype, pooled from three independent experiments), as well as the ratio (S-G2/M)/G1 among LSK CD34^−^ cells (right; *n* = 3 per genotype, from one experiment). Bars are means (SD). (D) Representative FACS profiles are shown. Note that Cre activation causes a reduction of Ki67^−^ LSK CD34^−^ cells in control compared with wild-type mice (not depicted). Similar results were obtained independently for LSK CD34^−^ and SLAM cells. (E) Levels of expression of cell cycle regulators in SLAM cells measured by RT-QPCR analysis. Bars are means (SD) of *n* = 4 mice; this experiment was performed twice. \*, P \< 0.05; \*\*\*, P \< 0.0005.](JEM_20122019_Fig3){#fig3}

*Nle* acts in a cell-autonomous manner to maintain hematopoiesis
----------------------------------------------------------------

In Nle^cKO^ mice, systemic *Nle* inactivation might contribute to BM failure. To examine this possibility, we performed noncompetitive transplantation between wild-type and control or Nle^cKO^ mice. In a first set of experiments, we transplanted BM cells from wild-type mice into sublethally irradiated untreated control or Nle^cKO^ mice ([Fig. 4 A](#fig4){ref-type="fig"}). In the reciprocal experiment, untreated control or Nle^cKO^ BM cells were transplanted into sublethally irradiated wild-type mice ([Fig. 4 B](#fig4){ref-type="fig"}). 2 mo after grafting, efficiently reconstituted (\>80%) mice were injected with tamoxifen and their BM were analyzed after 7 d, at a time point where a drastic BM phenotype was observed in Nle^cKO^ mice ([Fig. 1, F and H](#fig1){ref-type="fig"}; and [Fig. 2, A--C](#fig2){ref-type="fig"}). The number of wild-type LSK cells was not modified in an *Nle*-deficient environment compared with control ([Fig. 4 C](#fig4){ref-type="fig"}). In contrast, wild-type mice reconstituted with Nle^cKO^ BM exhibited a reduced number of LSK cells after *Nle* inactivation ([Fig. 4 D](#fig4){ref-type="fig"}). At longer time points, we observed the progressive disappearance of the *Nle^Del^* allele in BM and PB (not depicted). This shows that *Nle*-deficient HSCs are not able to maintain hematopoiesis in a wild-type environment and supports the notion that loss of HSCs and progenitors in Nle^cKO^ mice was caused by *Nle* loss of function in BM cells. Death of Nle^cKO^ mice reconstituted with wild-type BM 2 wk after tamoxifen injection indicates that *Nle* function is also required in nonhematopoietic cells for mouse survival (not depicted).

![***Nle* is required cell autonomously for HSC function.** (A and B) Schematic representation of the noncompetitive transplantation strategy. Wild-type BM was transplanted into irradiated control or Nle^cKO^ mice (A) and conversely (B). After 2 mo, mice were treated with tamoxifen for 5 d. (C and D) 7 d after the first injection, the number of LSK cells in the BM of grafted mice was measured. Bars are means (SD) of *n* = 8--10 mice per genotype from two independent experiments. (E) Scheme of the competitive transplantation experiment. Wild-type CD45.1×CD45.2 mice were irradiated and engrafted with a mix of donor CD45.2 control or Nle^cKO^ and competitor CD45.1 wild-type BM cells (ratio 1:3 or 1:4). After 2 mo, mice were injected with tamoxifen. (F) PCR analysis on BM or PB cells from competitive chimeras at different time points after Cre induction. Similar results were obtained from three independent experiments. (G) The percentage of CD45.2 donor--derived cells among Mac1^+^ PB cells was measured at different time points. Depicted are the means (SD) of *n* = 4 mice per genotype. Similar results were obtained twice independently. (H) The percentages of CD45.2 donor--derived cells among BM or SLAM cells were measured before and at different time points after Cre induction. Similar results were obtained from three independent experiments. Individual measures and means (horizontal bars) are shown. (I) Proportion of c-Kit^high^ cells among SLAM cells in competitive chimeras 7 d after Cre induction. Bars are means (SD) of *n* = 4 mice; this experiment was performed three times. \*, P \< 0.05; \*\*, P \< 0.005.](JEM_20122019R_Fig4){#fig4}

To address whether *Nle* acts in a cell-autonomous manner in hematopoietic cells under homeostatic conditions, we adopted a competitive chimera approach. Either untreated control or Nle^cKO^ CD45.2 donor BM cells were transplanted with an excess (1:3 to 1:4 ratio) of competitor wild-type CD45.1 BM cells into irradiated (CD45.1×CD45.2)F1 recipient mice ([Fig. 4 E](#fig4){ref-type="fig"}). In such chimeras, hematopoiesis can be sustained by competitor cells, therefore preventing secondary effects caused by the cytopenia that occurs both in Nle^cKO^ mice and noncompetitive chimeras. After stable reconstitution, mice were injected with tamoxifen, and PB and BM cells were analyzed at various time points. No differences in BM cellularity were observed between mice engrafted with Nle^cKO^ and control cells, confirming that BM homeostasis was maintained in these chimeras (not depicted). We also verified that efficient deletion of *Nle^Flox^* allele was obtained in these mice ([Fig. 4 F](#fig4){ref-type="fig"}). In PB, Nle^cKO^ CD45.2 Mac1^+^ myeloid cells were no longer detected from 20 d after injection onwards ([Fig. 4 G](#fig4){ref-type="fig"}). Long-lived CD3^+^ T and CD19^+^ B lymphoid cells were also affected, although with a delayed kinetics (not depicted). In agreement with the data obtained in the PB, Nle^cKO^ CD45.2 cells rapidly disappeared in the BM ([Fig. 4 H](#fig4){ref-type="fig"}, left). The evolution of CD45.2 cells was addressed at day 7 and at later time points, as soon as 3 wk after *Nle* inactivation, and contrary to control CD45.2 cells, virtually no Nle^cKO^ CD45.2 cells were detected in BM and within the SLAM compartment ([Fig. 4 H](#fig4){ref-type="fig"}), indicating that *Nle*-deficient HSCs were not maintained even in a wild-type microenvironment and during homeostasis. Under these conditions, the proportion of c-Kit^high^ cells among Nle^cKO^ CD45.2 SLAM cells was still reduced ([Fig. 4 I](#fig4){ref-type="fig"}), indicating that *Nle* deficiency in HSCs can intrinsically down-regulate c-Kit expression. Altogether, our data show that *Nle* is cell-autonomously required for the maintenance of functional HSCs under both homeostasis and cytopenic conditions.

*Nle* is dispensable for more restricted progenitors
----------------------------------------------------

Because hematopoietic cells are continuously and actively fueled by the HSC/MPP compartment, the rapid exhaustion of HSCs and immature progenitors in Nle^cKO^ mice could preclude the detection of a more direct role of *Nle* in restricted progenitors and differentiated cells. To examine this possibility, we first used an ex vivo differentiation assay. Untreated control and Nle^cKO^ HSC-enriched (Lin^−^ Sca-1^+^ c-Kit^+^ Flt3^−^) cells were FACS-sorted and plated on OP9 stromal cells. After 5 d of culture, immature LSK cells were no longer detected (not depicted), and a pulse of 4-hydroxy-tamoxifen (4-OHT) was added to the culture medium to induce loss of *Nle* function in progenitor cells. During the following days, both control and *Nle*-deficient cells underwent massive expansion ([Fig. 5 A](#fig5){ref-type="fig"}). Cells were harvested after a total of 12 d in culture and analyzed for differentiation markers. Under the conditions used, differentiation was biased toward myeloid lineage, but control and Nle^cKO^ cells were indistinguishable in their ability to give rise to Mac1^+^Gr1^+^ granulocytes ([Fig. 5 B, right](#fig5){ref-type="fig"}). Importantly, we checked that *Nle* was efficiently inactivated at days 6 and 12 by PCR analysis ([Fig. 5 B, left](#fig5){ref-type="fig"}). This suggests that myeloid progenitors were able to actively proliferate and differentiate in the absence of *Nle*.

![***Nle* is dispensable during myeloid and B cell differentiation.** (A and B) 200 sorted LSK Flt3^−^ cells per well were plated onto OP9 cells. After 5 d, 4-OHT was added to the culture medium for 2 d. (A) Proliferation curves (*n* = 4--9 from two independent experiments). SD is shown. n.s., not significant; P = 0.211. (B) Deletion was evaluated by PCR and myeloid differentiation was assessed at day 12 by flow cytometry after staining with Mac1 and Gr1 markers. Similar results were obtained in two independent experiments. (C--E) Analysis of CD19-control (*CD19^Cre/+^*; *Nle^Flox/+^*) and CD19-Nle^KO^ (*CD19^Cre/+^*; *Nle^Flox/null^*) mice. (C) PCR analysis on IgM^+^ and CD19^+^ sorted cells from BM and spleen. Data are representative of three individuals. (D) Representative FACS profile of CD19-control and CD19-Nle^KO^ BM, stained with IgM and CD19 markers. (E) Counts of pre-B cells (CD19^+^ IgM^−^), immature B cells (CD19^+^ IgM^+^) from BM, and mature B cells (CD19^+^ IgM^+^) from spleen of CD19-control and CD19-Nle^KO^ mice. Bars are means (SD) of *n* = 4--6 mice per genotype pooled from three independent experiments.](JEM_20122019R_Fig5){#fig5}

We also evaluated the role of *Nle* in vivo during B cell development using the *CD19-Cre* mouse line ([@bib56]). We generated *CD19^Cre/+^*; *Nle^Flox/+^* and *CD19^Cre/+^*; *Nle^Flox/null^* mice, named, respectively, CD19-control and CD19-Nle^KO^ mice. As already observed for other Flox alleles, CD19^Cre^-mediated *Nle* inactivation was an on-going process along B cell maturation ([Fig. 5 C](#fig5){ref-type="fig"}). Comparison of CD19-control and CD19-Nle^KO^ mice revealed no significant differences in the deletion efficiency of *Nle^Flox^* allele and in the numbers of BM pre-B cells, immature B cells, and splenic mature B cells ([Fig. 5, C--E](#fig5){ref-type="fig"}). Moreover, CD19-Nle^KO^ B cells were able to secrete steric IgM (not depicted), indicating that *Nle*-deficient mature B cells were not functionally impaired. Altogether, these data strongly suggest that contrary to HSCs and MPPs, *Nle* is dispensable for survival, proliferation, and maturation of more restricted progenitors.

*Nle* is required for large ribosomal subunit biogenesis
--------------------------------------------------------

In yeast, NLE orthologue Rsa4 acts as a pre-60S maturation factor, being essential for progression of ribosomal large subunit biogenesis and nuclear export ([@bib10]; [@bib62]; [@bib3]). Based on its high degree of conservation among eukaryotes ([@bib8]; [@bib17]), we hypothesized that NLE might also participate in pre-60S maturation in mouse cells. To address this possibility, we took advantage of *Rosa26^CreERT2/+^*; *Nle^Flox/null^* embryonic stem (ES) cells, in which *Nle* loss of function can be induced by addition of 4-OHT in the culture medium ([Fig. 6 A](#fig6){ref-type="fig"}). In ES cells, NLE localized to the nucleolus as indicated by the specific nucleolar immunostaining that partially colocalized with B23/nucleophosmin and was undetectable after 4-OHT treatment ([Fig. 6 B](#fig6){ref-type="fig"}). To investigate the involvement of *Nle* in ribosome biogenesis, total cellular extracts from treated and untreated ES cells were fractionated on a sucrose gradient. Immunoblot of untreated ES cells fractions indicated that NLE accumulated mainly in fractions 8--11, corresponding to 60S to 80S sedimentation coefficients ([Fig. 6 C](#fig6){ref-type="fig"}). In treated cells, the sedimentation profile was dramatically altered with a decrease in the amount of 60S subunit and 80S ribosomes and an increase of 40S subunit ([Fig. 6 D](#fig6){ref-type="fig"}). These observations are consistent with a role of NLE in pre-60S maturation.

![***Nle* is required for the large preribosomal subunit biogenesis in mouse ES cells.** (A) Western blot analysis on Nle^cKO^ cells untreated or treated with 4-OHT. This experiment was performed three times independently. (B) Immunostaining of NLE and B23 in *Rosa26^CreERT2/+^*; *Nle^Flox/null^* ES cells treated or not with 4-OHT. The pictures are representative of three independent experiments. Bars, 10 µm. (C) RNA profiles measured by absorbance at 260 nm in a sucrose gradient loaded with extracts from untreated cells. In each fraction, NLE and RPL24 protein levels, 28S and 18S rRNA, were assessed by immunoblotting and ethidium bromide staining, respectively. The arrow points to the NLE-specific band. (D) RNA profiles measured by absorbance at 260 nm loaded with extracts from untreated and treated cells at day 3. Similar results were obtained for two independent sedimentation profile experiments.](JEM_20122019_Fig6){#fig6}

In yeast, *Rsa4* deficiency has been shown to interfere with pre-60S nuclear export. We thus expected to observe a similar phenotype leading to accumulation of 5.8S and 28S rRNA precursors and decrease of the corresponding mature rRNA species in *Nle*-deficient ES cells ([Fig. 7 A](#fig7){ref-type="fig"}). We monitored the levels of different rRNA species in treated and untreated ES cells by Northern blot analysis ([Fig. 7, A--D](#fig7){ref-type="fig"}; and not depicted). Total RNA recovered from the same number of treated and untreated cells was probed with sequences specific for 5.8S, 18S, 28S, and its2. We observed a progressive reduction in the steady-state levels of 5.8S and 28S mature rRNA concomitantly with the accumulation of 12S and 32S rRNA precursors in mutant cells ([Fig. 7, B--D](#fig7){ref-type="fig"}). In contrast, processing of 18S rRNAs was not affected ([Fig. 7 B](#fig7){ref-type="fig"}). We confirmed these observations by RNA fluorescence in situ hybridization (FISH) using 5′ets, its1, and its2 probes recognizing various combinations of nucleolar rRNA species ([Fig. 7, A and E](#fig7){ref-type="fig"}). By flow cytometry, we measured an increase of the its2/its1 ratio, indicating a specific accumulation of rRNA precursors of the large subunit ([Fig. 7 F](#fig7){ref-type="fig"}). 45/47S levels measured by 5′ets signal intensity were unchanged (not depicted). Importantly, its2 levels were not affected after 4-OHT treatment of control ES cells ([Fig. 7 G](#fig7){ref-type="fig"}), demonstrating that the accumulation of immature rRNA precursors is indeed caused by *Nle* loss of function. Altogether, these data demonstrate that *Nle* is required in mouse ES cells for the maturation and the export of the large ribosomal subunit.

![***Nle* inactivation induces defects in rRNA maturation and accumulation of the large preribosomal subunit.** (A) Schematic representation of the two major pre-rRNA processing pathways in mammalian cells. Localization of probes is indicated under the 47S primary transcript. Predictions based on the known function of NLE orthologue in yeast of rRNA maturation defects in *Nle*-deficient mouse ES cells are shown in red. If this function is conserved, *Nle* inactivation should induce a block in the last steps of maturation of the large preribosomal subunit, leading to an accumulation in the nucleolus of the 32S and 12S pre-rRNA species and the decreased export in the cytoplasm of mature 28S and 5.8S rRNA. 32S and 12S pre-rRNA can be detected by Northern blot or FISH analysis using probes directed against the pre-rRNA internal sequence its2 (blue). Maturation of the small subunit should not be directly affected. Thereby, the levels of the corresponding pre-rRNA detected with an its1 probe (green) should remain unchanged. Similarly, levels of 47S primary rRNA transcript detected with a 5′ets probe (purple) should not be directly affected. (B--D) Northern blot analysis of total RNA from untreated or treated ES cells. (B) Quantification of 12S/5.8S, 32S/28S, and 30S/18S intensity ratios. Northern blots analysis with 28S, 18S, 5.8S, or its2 probe was obtained at least twice. (E--G) FISH experiment on untreated and treated ES cells. (E) Representative images of two independent FISH experiments with its2, its1, or 5′ets performed on ES cells untreated or treated with 4-OHT at day 3. Cells were labeled with Hoechst. Bar, 5 µm. (F) Representative FACS profiles of its2 FISH signal in untreated and treated ES cells. Quantification of the its2/its1 intensity ratio relative to untreated cells is shown. Bars are means (SD) of *n* = 3 per condition from one out of three independent experiments. \*, P \< 0.05. (G) Control (*Rosa26^CreERT2/+^*; *Nle^Flox/+^*) ES cells were treated or not with 4-OHT. At day 3, FISH experiments using its2 probe and PCR analysis were performed showing that in the presence of a remaining functional *Nle* allele, large ribosomal subunit maturation was not affected.](JEM_20122019_Fig7){#fig7}

*Nle* deletion affects ribosome biogenesis specifically in HSCs and MPPs
------------------------------------------------------------------------

Having established the role of *Nle* in ES cells, we next wondered whether defects in ribosome biogenesis could be responsible for the BM phenotype observed in Nle^cKO^ mice. We combined cell surface antibody staining with intracellular RNA FISH and used flow cytometry to measured steady-state levels of rRNA precursors in several BM cell populations. We first checked that as in ES cells, RNA FISH with its2 probes labeled subnuclear structures, poor in chromatin, likely to correspond to nucleoli in immature cells and B cells ([Fig. 8 A](#fig8){ref-type="fig"}). 3 d after Cre induction, we measured a shift in its2 intensity in *Nle*-deficient SLAM and Lin^−^ Sca-1^+^ CD150^+^ CD48^+^ MPPs but not in more committed Lin^+^ cells ([Fig. 8, B and C](#fig8){ref-type="fig"}, left). Importantly, neither its1 nor 5′ets levels were modified in stem cells and MPPs, pointing to defective large ribosomal subunit maturation in HSCs/MPPs ([Fig. 8, B and C](#fig8){ref-type="fig"}; and not depicted). Accumulation of immature rRNAs of the large subunit in SLAM and Lin^−^ Sca-1^+^ CD150^+^ CD48^+^ cells was confirmed by RT-QPCR ([Fig. 8 C](#fig8){ref-type="fig"}, right). 5 d after Cre induction, a similar situation was observed ([Fig. 8 B](#fig8){ref-type="fig"}, right). We performed similar analysis on B cell lineage populations from CD19-control and CD19-Nle^KO^ mice. Consistent with the lack of a phenotype in CD19-Nle^KO^ mice, no changes in the level of its2, its1, or 5′ets were observed in BM and spleen B cells ([Fig. 8, D and E](#fig8){ref-type="fig"}; and not depicted). We thus conclude from these experiments that *Nle* is differentially required for 60S ribosomal subunit biogenesis between HSCs/MPPs and more committed or differentiated hematopoietic cells.

![***Nle* is required for pre-60S export in HSCs/MPPs but not in B cells.** (A) Its2 labeling in hematopoietic cells. At day 3, control and Nle^cKO^ hematopoietic cells were stained with c-Kit antibody and its2 probe (left). CD19-control and CD19-Nle^KO^ cells from BM and spleen were stained with IgM antibody and its2 probe (right). Bar, 5 µm. (B) Representative histograms for its2 and its1 labeling in SLAM cells, immature progenitors (Lin^−^ Sca-1^+^ CD150^+^ CD48^+^ or Lin^−^ Sca-1^−^ c-Kit^+^), and Lin^+^ cells at day 3 or 5 after Cre induction from control and Nle^cKO^ mice. Three independent FACS experiments showed similar results. (C) Quantification of its2/its1 intensity and RNA level ratios in populations from control and Nle^cKO^ mice measured at day 3 by FISH (left) or RT-QPCR (right). Bars are means (SD) of *n* = 3--4 mice per genotype. Data are from one representative of two experiments. \*, P \< 0.05. (D) Representative histograms for its2 labeling by FISH in BM pre-B and immature B cells and splenic B cells from CD19-control and CD19-Nle^KO^ mice. (E) Quantification of its2/its1 intensity ratio in B cell populations from CD19-control and CD19-Nle^KO^ mice. Bars are means (SD) of *n* = 3 mice per genotype from one experiment.](JEM_20122019_Fig8){#fig8}

Rapid BM cytopenia is mediated by *p53*
---------------------------------------

Defective ribosome biogenesis was shown to trigger the activation of p53 pathway in vertebrate cells ([@bib67]). We therefore monitored p53 expression levels in BM cells shortly after *Nle* inactivation. 4 d after Cre induction, we measured a clear increased in p53 levels in both *Nle*-deficient SLAM and Lin^−^ Sca-1^+^ CD150^+^ CD48^+^ cells ([Fig. 9](#fig9){ref-type="fig"}, A \[left\] and B). In contrast, in Nle^cKO^ Lin^+^ cells and CD19-Nle^KO^ B cells, in which no increases in pre-60S rRNA intermediates were observed, p53 levels were not augmented ([Fig. 9](#fig9){ref-type="fig"}, A \[right\] and C). We next assessed the transcriptional activation of various p53 target genes in these compartments. In addition to *Cdkn1a* (*p21*; [Fig. 3 E](#fig3){ref-type="fig"}), mRNA levels of *Bax*, *Noxa*, *Puma*, and *Sestrin2* were significantly increased in SLAM or Lin^−^ Sca-1^+^ CD150^+^ CD48^+^ cells ([Fig. 9 D](#fig9){ref-type="fig"}), further confirming the activation of p53 after *Nle* inactivation. To determine the functional implication of p53 in the severe hematopoietic phenotype of Nle^cKO^ mice, we crossed *p53^−/−^* mice with Nle^cKO^ mice and analyzed BM cell populations after tamoxifen injection. Strikingly, loss of *p53* totally rescued the number of total BM and LSK cells in Nle^cKO^ mice 5 d after Cre induction ([Fig. 9 E](#fig9){ref-type="fig"}). Accordingly, the number of SLAM cells in Nle^cKO^; *p53^−/−^* mice was unchanged compared with control mice (not depicted). Importantly, Nle^cKO^; *p53^−/−^* SLAM and Lin^−^ Sca-1^+^ CD150^+^ CD48^+^ cells exhibited increased its2 levels compared with controls ([Fig. 9 F](#fig9){ref-type="fig"}). The fact that its2 levels were significantly higher in these mice compared with Nle^cKO^ mice suggests that the p53-dependent checkpoint operates at a relatively early step of pre-60S rRNA intermediate accumulation in these cell populations. Collectively, our data suggest that *Nle* deficiency leads to defective ribosome biogenesis and consecutive p53 activation in HSCs and MPPs that in turn causes their disappearance.

![**Rapid BM cytopenia is mediated by *p53*.** (A, left) Representative histograms for p53 labeling in SLAM cells and MPPs (Lin^−^ Sca-1^+^ CD150^+^ CD48^+^) at day 4 after Cre induction from control and Nle^cKO^ mice. (right) Representative histograms for p53 labeling in BM pre-B and immature B cells from CD19-control and CD19-Nle^KO^ mice. (B) Quantification of p53 levels in populations from control and cKO mice. Bars are means (SD) of *n* = 4 mice per genotype. (C) Quantification of p53 levels in B cell populations from CD19-control and CD19-Nle^KO^ mice. Bars are means (SD) of *n* = 3 mice per genotype. Data are from one representative of two experiments. (D) Relative expression levels of p53 target genes measured by RT-QPCR in SLAM cells and MPPs from control and Nle^cKO^ mice at day 4 after Cre induction. Bars are means (SD) of *n* = 4 mice. Data are from one representative of two experiments. (E) Representative FACS profiles obtained 5 d after Cre induction from control, Nle^cKO^, and Nle^cKO^ *p53^−/−^* (*Rosa26^CreERT2/+^*; *Nle^Flox/null^*; *p53^−/−^*) mice. The BM cellularity and the number of LSK cells are shown for the three genotypes. Bars are means (SD) for *n* = 4--6 mice per genotype. This experiment was performed twice. (F) Its2 labeling by FISH was performed on BM cells from control, Nle^cKO^, and Nle^cKO^ *p53^−/−^* mice 5 d after Cre induction. Representative histograms for the levels of its2 in SLAM cells and MPPs (Lin^−^ Sca-1^+^ CD150^+^ CD48^+^) and quantification of its2 intensity are shown. Bars are means (SD) for *n* = 4--6 mice per genotype. This experiment was performed twice. \*, P \< 0.05.](JEM_20122019R_Fig9){#fig9}

DISCUSSION
==========

In this study, we show that *Nle* is critically required for the maintenance of adult HSCs. Collectively, our data demonstrate that *Nle* is an intrinsic regulator, acting in a cell-autonomous manner, and necessary for HSC self-renewal. By demonstrating that *Nle* function in the pre-60S ribosomal subunit maturation has been conserved during evolution, we underscore the importance of ribosome biogenesis as a critical pathway for HSC maintenance. In contrast, *Nle* function is dispensable in restricted progenitors and differentiated hematopoietic cells, indicating that ribosome biogenesis is differentially regulated during differentiation.

*Nle* is a key regulator of HSC maintenance
-------------------------------------------

Strikingly, *Nle*-deficient cells were rapidly eliminated from the HSC population. Although several factors have been shown to participate in HSC regulation, rapid loss of the HSC pool has been reported after the disruption of only a few genes: *N-Myc*/*c-Myc*, *NKAP*, *Cited2*, *Mll*, *Survivin*, *Mcl-1*, or *APC* ([@bib50]; [@bib29]; [@bib37]; [@bib36]; [@bib54]; [@bib34]; [@bib52]). Of note, one of the primordial functions of *Myc* is the regulation of ribosome biogenesis ([@bib63]; [@bib28]). Combined deficiency of *c-Myc* and *N-Myc* has been shown to severely impair HSC function, and interestingly, down-regulation of 31 ribosomal proteins coding genes has been reported in mutant HSCs ([@bib36]). However, contribution of defective ribosome biogenesis to the phenotype of *c-Myc*/*N-Myc* double-deficient HSCs has not been investigated.

Concomitantly with HSC loss, we observed the down-regulation of c-Kit expression at the cell surface of Nle^cKO^ immature hematopoietic cells. c-Kit is a major regulator of HSC survival and proliferation, and its down-regulation may therefore participate in defective maintenance of Nle^cKO^ HSCs. In *Gfi1^−/−^* mice, a slight decrease of c-Kit in LSK cells correlates with progressive loss of HSC self-renewal activity ([@bib23]). Reduced c-Kit expression might also reflect HSC activation consecutive to BM depletion ([@bib55]; [@bib36]). Nle^cKO^ HSCs displayed reduced expression of c-Kit receptor under homeostatic conditions, indicating that such deregulation is not solely the consequence of BM cytopenia. How c-Kit expression is regulated in HSCs is not fully understood. Recently, the Shp2 tyrosine phosphatase was shown to promote *Kit* gene expression and HSC pool maintenance through a positive c-Kit/Shp2/*c-Kit* feedback loop ([@bib68]). 4 d after Cre induction, a ≈30% decrease in *c-Kit* mRNA levels was observed in Nle^cKO^ HSCs/MPPs (unpublished data), suggesting that c-Kit down-regulation at their membranes was controlled at least in part at the transcriptional level. Future work will be necessary to understand the mechanisms underlying c-Kit down-regulation in *Nle*-deficient HSCs.

*Nle* acts in ribosome biogenesis and is likely not a direct regulator of Notch
-------------------------------------------------------------------------------

Based on genetic study in *Drosophila*, *Nle* has been proposed to code for a modulator of Notch signaling. Absence of canonical Notch signaling does not impact HSC maintenance at homeostasis ([@bib39]). Conversely, sustained Notch activity promotes HSC expansion ex vivo and enhanced self-renewal of hematopoietic progenitors ([@bib4]). Thus, modulation of Notch signaling cannot simply account for the failure of *Nle*-deficient HSCs/MPPs. Contrary to genes coding for key components of the Notch pathway that are specific to metazoans, *Nle* is an ancient eukaryotic gene ([@bib17]), and its ancestral function as a ribosome biogenesis factor has been deciphered in yeast ([@bib10]; [@bib62]). Here, we show that *Nle* function has been conserved during evolution. Although we cannot formally exclude the possibility that NLE has acquired additional nonribosomal functions during evolution, it seems more likely that Notch activity modulation by NLE is related to its role in ribosome biogenesis. Genetic interactions between Notch and Minute mutations, which affect a class of ribosomal genes, have been reported a very long time ago ([@bib58]). More recently, genetic screens for modifiers of Notch activity have identified several ribosomal proteins ([@bib20]; [@bib41]). In particular genetic and cellular contexts, Notch signaling activity must therefore be sensitive to variations in ribosome supply as previously discussed for the Hedgehog signaling pathway ([@bib47]).

Mechanisms responsible for the rapid exhaustion of HSCs/MPPs and BM failure
---------------------------------------------------------------------------

Using a cellular system, we showed that *Nle* loss of function induced defective pre-60S subunit maturation and export, leading to the rapid diminution of free ribosomes. In vivo, by combining rRNA FISH and flow cytometry, we were able to detect alterations in ribosome biogenesis in HSCs and immature progenitors at early time points after *Nle* inactivation. This suggests that these defects cause HSC/MPP exhaustion in Nle^cKO^ mice. Defective ribosome biogenesis might cause HSC elimination through several mechanisms. A shortage of ribosomes would affect translation at a global level, although IRES-mediated translation may be more sensitive to ribosome insufficiency than a cap-dependent one ([@bib24]). Preferential translation of mRNAs with a 5′ terminal oligopyrimidine tract has also been reported upon defective ribosome biogenesis ([@bib14]). In addition, suppressed translation of a specific subset of mRNAs has been observed upon ribosomal protein haploinsufficiency/knockdown ([@bib33]; [@bib24]). Therefore, altered translation of transcripts essential for HSC function might contribute to the phenotype of Nle^cKO^ mice. Impaired ribosome biogenesis is known to efficiently trigger the up-regulation of p53 function through binding of MDM2 by free ribosomal proteins RPL11, RPL23, RPL5, or RPS7 ([@bib67]). Consistently, we demonstrated the rapid activation of the p53 pathway in *Nle*-deficient HSCs/MPPs. Up-regulation of the proapoptotic genes *Bax*, *Puma*, and *Noxa* in these compartments suggests that apoptosis may actively contribute to their elimination. However Annexin V and TUNEL stainings failed to unravel increased cell death in *Nle*-deficient HSCs/MPPs. The reasons for this discrepancy are yet unclear but may be caused by the rapid clearance of dying mutant cells in the BM or the fact that these dying cells lose some of their surface markers and therefore were not included in our analyses. As a complementary approach, we performed deletion of *Nle* in vitro in sorted HSC/MPP populations. Unfortunately, in vitro Cre activation in these populations compromises their maintenance and disabled us from using this assay to assess apoptosis in these cells. Other cellular responses to p53 activation may also participate in the exhaustion of *Nle*-deficient HSCs/MPPs. Hence, it has been suggested that p53 negatively regulates self-renewal of HSCs and MPPs, although how p53 regulates this process is not precisely understood ([@bib2]; [@bib7]). Induction of differentiation was also shown to represent an effective response to stress in various stem cell populations ([@bib25]; [@bib38]; [@bib65]). Thus, it will be interesting to determine whether premature differentiation could be induced by defective ribosome biogenesis in *Nle*-deficient HSCs, thereby contributing to their exhaustion. Regardless the underlying molecular mechanisms, disappearance of *Nle*-deficient HSCs/MPPs is genetically dependent on p53. In the absence of p53, Nle^cKO^ HSCs and immature progenitor populations were unaffected, although accumulation of pre-60S rRNA intermediates was still observed. Further analyses at later time points will be required to determine whether and how impaired ribosome biogenesis consecutive to NLE depletion affects HSC functionality independently of the p53-dependent ribosome biogenesis checkpoint.

Differential requirement of NLE function
----------------------------------------

Considering its conserved and critical role in large ribosomal subunit biogenesis, our observation that NLE is dispensable in restricted progenitors was unexpected. Importantly, we did not detect accumulation of rRNA intermediates in *Nle*-deficient B and Lin^+^ cells, suggesting that pre-60S maturation occurs normally in the absence of NLE in these cells. Notably, normal proliferation, differentiation, and maturation of B cell lineage after constitutive inactivation of *Nle* with the CD19-Cre driver strengthens this conclusion and argues against the hypothesis that long-lasting inherited ribosomes could compensate for a defective ribosome biogenesis. Collectively, our findings support the hypothesis that alternative *Nle*-independent pathways can assure 60S subunit production in restricted progenitors but not in HSCs/MPPs ([Fig. 10](#fig10){ref-type="fig"}). An NLE-related WD-repeat protein, WDR12/Ytm1, containing an N-terminal domain homologous to the NLE N-terminal domain is present in all eukaryotes and also participates in pre-60S maturation ([@bib44]; [@bib3]). However, WDR12/Ytm1 and NLE/Rsa4 have been shown to act sequentially and in a nonredundant manner during pre-60S subunit maturation in yeast ([@bib62]; [@bib3]). Ribosome biogenesis has been extensively studied in yeast, but is yet poorly described in higher eukaryotes. Several differences have been reported between yeast and higher eukaryotic cells in terms of rRNA maturation steps or composition of preribosomal particles (see for example, [@bib61]; [@bib59]). Whether ribosome biogenesis is qualitatively modulated during development or between cell types in a pluricellular organism is still an open question. This study is to our knowledge the first in vivo demonstration that differences in ribosome biogenesis exist between cell types in mammals. Recently, the ribosomal filter hypothesis postulating that differences in composition of ribosomal subunit or posttranslational modifications of ribosomal proteins may differentially affect the translation of particular transcripts has received support from studies performed in budding yeast and mouse embryo ([@bib32]; [@bib33]). If this is true, ribosome heterogeneity implies some degrees of plasticity during preribosomal subunit assembly. Differential activities of alternative pathways for 60S subunit maturation between HSCs/MPPs and restricted progenitors could thus lead to the generation of qualitatively distinct ribosomes and therefore would represent an additional mode of gene expression regulation.

![**Model for the role of *Nle* in hematopoietic cells.** In HSCs/MPPs, *Nle* is absolutely required for proper 60S subunit biogenesis. In the absence of *Nle*, the pathway is impaired and the pre-60S subunit accumulates within the nucleus. In more committed progenitors and differentiated cells, an *Nle*-independent pathway is active and allows the production of the 60S subunit in absence of *Nle*.](JEM_20122019_Fig10){#fig10}

Concluding remarks
------------------

The expression of several genes involved in ribosome biogenesis is highly enriched in *Drosophila* ovarian stem cells ([@bib30]) and fish neural stem cells (Joly, J.-S., personal communication). A genome-wide gain of function screen in mouse ES cells identified multifunctional nucleolar proteins involved notably in ribosome biogenesis as novel regulators of self-renewal ([@bib1]). Similarly, genetic screens for mutants that affect neuroblast and ovarian germline stem cell maintenance in *Drosophila* identified genes involved in ribosome biogenesis ([@bib12]; [@bib46]). Together with our findings, these observations link ribosome biogenesis with stem cell biology. Beyond overall protein synthesis and cell growth, specificities in preribosomal factors or ribosomal protein expression may contribute to stem cell/immature progenitor identity. In the future, it will be important to address whether such specificities and in particular dependency on the NLE pre-60S maturation pathway contribute to self-renewal capacity of malignant cells.

MATERIALS AND METHODS
=====================

### Mice.

Experiments on live mice were conducted according to the French and European regulations on care and protection of laboratory animals (EC Directive 86/609, French Law 2001-486 issued on June 6, 2001) and the National Institutes of Health Animal Welfare (Insurance \#A5476-01 issued on 02/07/2007). Control and Nle^cKO^ animals were obtained by crossing mice harboring *Nle^Flox^* (Fig. S1), *Nle^null^* ([@bib8]), *Rosa26^CreERT2^* ([@bib21]), *CD19^Cre^* ([@bib56]), or *p53^−^* ([@bib27]) alleles. Mice were injected intraperitoneally with 75 mg/kg tamoxifen for three or five consecutive days. Nle^cKO^ mice were systematically compared with control littermates treated under the same conditions.

### *Nle* gene targeting and ES cell culture.

ES cells were cultured in DMEM + GlutaMAX-I (Gibco) supplemented with 15% FCS, 100 µM β-mercaptoethanol, 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 10^3^ U/ml LIF. *Nle^Flox/+^* ES cells were obtained by homologous recombination in CK35 129/Sv ES cells ([@bib35]; for details see Fig. S1). Control and Nle^cKO^ ES cells were obtained by iterative gene targeting. *Nle^Flox/+^* ES cells were electroporated with the *Nle^nLacZ^* targeting vector ([@bib8]) to generate *Nle^Flox/null^* ES clones. Then, SfiI-linearized pRosaCreERT2 targeting vector ([@bib21]) was electroporated into *Nle^Flox/+^* and *Nle^Flox/null^* ES cells to generate control (*Rosa26^CreERT2/+^*; *Nle^Flox/+^*) and Nle^cKO^ (*Rosa26^CreERT2/+^*; *Nle^Flox/null^*) ES cells, respectively. The deletion of the *Nle^Flox^* allele in culture was induced by treatment with 1 µM 4-OHT for two consecutive days.

### Antibodies.

We raised an anti-NLE polyclonal antibody in rabbit. Recombinant fusion peptide corresponding to amino acids 1--174 of the NLE protein was produced in *Escherichia coli* as a His-tagged protein from pET15b expression vector (EMD Millipore) and purified using immobilized metal ion affinity chromatography. Purified peptide was then used as an immunogen for the production of rabbit antiserum (Agro-Bio). Antibody was used at 1:50 and 1:500 dilutions for immunofluorescence and immunoblotting, respectively. Antibodies used for flow cytometry are listed in [Table S1](http://www.jem.org/cgi/content/full/jem.20122019/DC1){#supp3}.

### Flow cytometry analysis.

Single cell suspensions of BM, spleen, and PB were stained with different combinations of antibodies. Marker combinations and FACS gating strategy used to define the various BM cell populations are indicated in Fig. S2. Apoptosis was monitored using 7AAD and Annexin V (Roche) according to the manufacturer's instructions. For proliferation analysis and p53 labeling, cells were incubated with fixation/permeabilization solution (eBioscience) and stained either with anti-Ki67 (B56; BD) antibody and 10 µg/ml Hoechst 33342 or with p53 antibody (CM5; Novocastra) and Alexa Fluor 488--conjugated anti--rabbit secondary antibody, respectively. CyAn ADP, FACSCanto, and LSR Fortessa (BD) flow cytometers were used for analysis. Sorting was performed using the MoFlo cytometer (Beckman Coulter) or the AutoMACS technology (Miltenyi Biotec). Data were analyzed with FlowJo software (Tree Star).

### Ex vivo differentiation assay.

HSCs were cultured on an OP9 monolayer in Opti-MEM, 10% FCS, 100 µM β-mercaptoethanol, 100 U/ml penicillin, 0.1 mg/ml streptomycin, Il-7, Flt3 ligand, and GM-CSF (supernatants of cell lines transfected with expression vectors for IL-7, Flt3 ligand, and GM-CSF, respectively; a gift from F. Melchers, Max Planck Institute for Infection Biology, Berlin, Germany).

### Transplantation assays.

For noncompetitive transplantations, ∼8 × 10^5^ Lin^−^ cells from control or Nle^cKO^ mice (129Sv/C57BL/6 mixed background) were injected into the retroorbital sinus of sublethally irradiated (11 Grays) (129Sv×C57Bl6)F1 mice carrying the Act-GFP transgene ([@bib49]). BM was depleted from lineage-positive cells to avoid graft versus host reaction. The converse transplantation was performed similarly using donor and recipient mice selected for histocompatibility matching through genotyping of the chromosome 17 region encompassing major MHC class I loci. For competitive transplantations, Lin^−^ control or Nle^cKO^ cells (CD45.2, 129Sv/C57Bl6 mix) were mixed with an excess (3:1 or 4:1 ratio) of competitor cells (CD45.1, C57BL/6) and grafted into a sublethally irradiated recipient (CD45.1×CD45.2, (129Sv×C57Bl6)F1). 2 mo after grafting, the reconstitution rate was assayed by flow cytometry analysis of PB cells using either GFP expression or CD45.1/45.2 immunostaining (noncompetitive and competitive transplantations, respectively).

### Northern blot analysis.

Total RNA from ES cells was prepared with TRIzol reagent (Sigma-Aldrich) according to the supplier's instructions. Migration and hybridization were performed as previously described ([@bib12]). The probes used in this study were 5.8S (5′-GCGTTCGAAGTGTCGATGATCAATGTGTCCTGCAATTCAC-3′), 18S (5′-ACGGTATCTGATCGTCTTCGAACC-3′), 28S (5′-GTTCCCTTGGCTGTGGTTTCGCTAGATA-3′), and its2 (5′-ACTGGTGAGGCAGCGGTCCGGGAGGCGCCGACG-3′).

### Sucrose density gradient.

Cells were treated for 10 min with 10 mg/ml cycloheximide (Sigma-Aldrich) in cell culture medium, collected, and then resuspended in buffer lysis (50 mM Tris-Hcl, pH 7.4, 50 mM Kcl, 10 mM MgAc, 1 mM DTT \[Invitrogen\], 200 U/ml RNasin \[Promega\], 1 tablet/10 ml proteases inhibitors \[Roche\], and 10 mg/ml cycloheximide \[Sigma-Aldrich\]). 200-µl glass beads were added to cell suspension, and lysis was performed by vortexing cells at 4°C, for 1 min, five times. After centrifugation, supernatants were layered on a 15--50% sucrose gradient and centrifuged for 15 h at 33,000 rpm in an SW41 rotor (Beckman Coulter). The gradient was fractionated with a fractions collector system coupled to a UV detector to monitor absorbance at 260 nm. Half of each fraction was treated with trichloroacetic acid to recover proteins, whereas the remaining half was treated with phenol-chloroform to extract RNA.

### FISH analysis.

ES cells or stained hematopoietic cells were fixed for 30 min with 4% PFA, rinsed in PBS, and placed in 70% ethanol at 4°C. The hybridization was performed as previously described ([@bib48]). Cy3 conjugated probes were purchased at Eurogentec (Its1, 5′-TAGACACGGAAGAGCCGGACGGGAAAGA-3′; its2, 5′-GCGATTGATCGTCAACCGACGCTC-3′; and 5′ets, 5′-AGAGAAAAGAGCGGAGGTTCGGGACTCCAA-3′).

### Genotyping of mice and cells.

Genotyping was performed by PCR after lysis of tissue and ES cell pellet in the following buffer: 50 mM Tris, pH 8.5, 100 mM NaCl, 0.5% Tween 20, and 100 mg/ml proteinase K at 56°C overnight, followed by a 10-min incubation at 96°C. For *Nle*, PCR amplification with primers a (5′-CAGACTTTCTTATTGGGGTTTGGT-3′), b (5′-TAGCCCTGGCTGACCTAGAA-3′), b′ (5′-TCCCCTCGAGGGACCTAATA-3′), and c (5′-ATGCCCGGCGTGTTAAGATT-3′) allowed us to discriminate *Nle^wt^* (538 bp, primers a and b), *Nle^Flox^* (439 bp, primers a and b′), and *Nle^Del^* (773 bp, primers a and c) alleles. D17mit24 and D17Mit135 polymorphic markers were used to discriminate between 129Sv and C57BL/6 alleles around MCH class I loci.

### Statistical analysis.

For all bar graphs with pooled data, means (SD) are shown. Statistical analyses were performed using the Mann--Whitney Wilcoxon test. Significance is indicated on the figures with the following convention: \*, P \< 0.05; \*\*, P \< 0.005; \*\*\*, P \< 0.0005.

### Real-time RT-PCR.

mRNA from sorted cells was purified using either the Dynabeads mRNA direct kit (Invitrogen) or RNeasy Plus Micro kit (QIAGEN) and reverse-transcribed using the SuperScript Vilo cDNA synthesis kit (Invitrogen), according to the manufacturers' instructions. Real-time PCR was then performed using custom-designed primers (compare in [Table S2](http://www.jem.org/cgi/content/full/jem.20122019/DC1){#supp4}) and SYBR green PCR master mix on a StepOne instrument (StepOne software version 2.2; Applied Biosystems) or, alternatively, with the Fluidigm Biomark EvaGreen qPCR system (Fluidigm Real-Time PCR analysis software version 3.1.3; Fluidigm). Expression levels were normalized using several housekeeping genes, including *TBP*, *Tubulin β 5*, *Aldolase*, *TfIID*, and *Rrm*.

### Online supplemental material.

Fig. S1 describes the generation of the *Nle^Flox^* allele by homologous recombination in ES cells. Fig. S2 shows hierarchical relations of various hematopoietic cell populations defined by marker combinations and illustrates the FACS-gating strategy used for analysis. Table S1 lists the antibodies used for flow cytometry. Table S2 lists the sequence primers used for real-time RT-PCR. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20122019/DC1>.
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